Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Gross Profit 2008–2025
Regeneron Pharmaceuticals, Inc. annual/quarterly gross profit history and growth rate from 2008 to 2018. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Regeneron Pharmaceuticals, Inc. gross profit for the quarter ending March 31, 2018 was 1.4 B, a 14.67% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. gross profit for the twelve months ending March 31, 2018 was 5.6 B, a 22.59% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. annual gross profit for 2019 was 6.2 B, a 25.40% increase from 2018.
- Regeneron Pharmaceuticals, Inc. annual gross profit for 2018 was 4.9 B, a 13.43% decrease from 2017.
- Regeneron Pharmaceuticals, Inc. annual gross profit for 2017 was 5.7 B, a 21.52% increase from 2016.
- Regeneron Pharmaceuticals, Inc. annual gross profit for 2016 was 4.7 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Regeneron Pharmaceuticals Inc. Gross Profit — FAQ
Regeneron Pharmaceuticals Inc. (REGN) gross profit over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's gross profit history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.